ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers.
AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...
A research team led by Prof. HOU Xingliang from the South China Botanical Garden of the Chinese Academy of Sciences has used genome-wide association ...
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures The ideas and opinions expressed in this Data Supplement do not necessarily ...